Chiriac, U.; Rau, H.; Frey, O.R.; Röhr, A.C.; Klein, S.; Meyer, A.L.; Morath, B.
Validation and Application of an HPLC-UV Method for Routine Therapeutic Drug Monitoring of Dalbavancin. Antibiotics 2022, 11, 541.
https://doi.org/10.3390/antibiotics11050541
AMA Style
Chiriac U, Rau H, Frey OR, Röhr AC, Klein S, Meyer AL, Morath B.
Validation and Application of an HPLC-UV Method for Routine Therapeutic Drug Monitoring of Dalbavancin. Antibiotics. 2022; 11(5):541.
https://doi.org/10.3390/antibiotics11050541
Chicago/Turabian Style
Chiriac, Ute, Heike Rau, Otto R. Frey, Anka C. Röhr, Sabrina Klein, Anna L. Meyer, and Benedict Morath.
2022. "Validation and Application of an HPLC-UV Method for Routine Therapeutic Drug Monitoring of Dalbavancin" Antibiotics 11, no. 5: 541.
https://doi.org/10.3390/antibiotics11050541
APA Style
Chiriac, U., Rau, H., Frey, O. R., Röhr, A. C., Klein, S., Meyer, A. L., & Morath, B.
(2022). Validation and Application of an HPLC-UV Method for Routine Therapeutic Drug Monitoring of Dalbavancin. Antibiotics, 11(5), 541.
https://doi.org/10.3390/antibiotics11050541